WallStSmart
CLB

Core Laboratories NV

NYSE: CLB · ENERGY · OIL & GAS EQUIPMENT & SERVICES

$14.65
-15.35% today

Updated 2026-04-30

Market cap
$803.54M
P/E ratio
27.70
P/S ratio
1.53x
EPS (TTM)
$0.63
Dividend yield
0.23%
52W range
$10 – $20
Volume
0.4M

WallStSmart proprietary scores

49
out of 100
Grade: C
Sell
Investment rating
4.0
Growth
C
7.0
Quality
B+
5.5
Profitability
C+
6.7
Valuation
B
4/9
Piotroski F-Score
Moderate
2.3
Altman Z-Score
Grey zone
Industry rank
View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target
$16.33
+11.51%
12-Month target
$12.68
-13.42%
Intrinsic (DCF)
$60.73
Margin of safety
+68.81%
1 Strong Buy0 Buy1 Hold0 Sell1 Strong Sell

Price chart

X-Ray snapshot

Strengths
+ Free cash flow $3.96M — positive
+ 68.81% below intrinsic value
Risks
No major risks identified

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$489.74M$509.79M$523.85M$526.52M$526.52M
Net income$19.45M$36.67M$31.40M$31.80M$-789000.00
EPS$0.63
Free cash flow$14.74M$14.21M$43.36M$22.59M$3.96M
Profit margin3.97%7.19%5.99%6.04%5.64%

Recent insider activity

DateInsiderTypeSharesPrice
2023-04-01VAN, DIJKEN EEUWIJK MONIQUESale5,485
2023-04-01VAN, DIJKEN EEUWIJK MONIQUEBuy5,485
2023-04-01TEMENG, KWAKUBuy6,419

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
CLB$803.54M494.05.56.77.0+68.81%Hold
XOM$642.90B502.06.04.76.5-46.34%Buy
CVX$382.88B462.05.04.74.0-54.61%Hold
SHEL$252.85B614.75.56.76.0+4.20%Buy
TTE$205.37B552.05.57.05.0Buy
COP$153.24B542.06.54.75.0-49.20%Buy

Smart narrative

Core Laboratories NV trades at $14.65. representing a P/E of 27.70x trailing earnings. Our Smart Value Score of 49/100 indicates the stock is fair. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 2.25, it sits in the grey zone. TTM revenue stands at $526.52M. with profit margins at 5.64%. Our DCF model estimates intrinsic value at $60.73.

Frequently asked questions

What is Core Laboratories NV's stock price?
Core Laboratories NV (CLB) trades at $14.65.
Is Core Laboratories NV overvalued?
Smart Value Score 49/100 (Grade C, Sell). DCF value $60.73.
What is the price target of Core Laboratories NV (CLB)?
The analyst target price is $16.33, representing +11.5% upside from the current price of $14.65.
What is the intrinsic value of Core Laboratories NV (CLB)?
Based on our DCF model, intrinsic value is $60.73, a +68.8% margin of safety versus $14.65.
What is the future stock price of CLB by 2030?
Our revenue-driven model estimates Core Laboratories NV could reach $16.96 by 2030, based on historical CAGR, margin trends, and capped P/E multiples.
What is Core Laboratories NV's revenue?
TTM revenue is $526.52M.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
2.25 — grey zone.

Company info

SectorENERGY
IndustryOIL & GAS EQUIPMENT & SERVICES
CountryUSA
ExchangeNYSE
CurrencyUSD

Quick metrics

P/S ratio1.53x
ROE11.60%
Beta1.16
50D MA$16.86
200D MA$15.02
Shares out0.05B
Float0.05B
Short ratio
Avg volume0.4M

Performance

1 week-1.64%
1 month-0.12%
3 months-14.61%
YTD+4.62%
1 year
3 years
5 years